Health Care • Medical/Nursing Services
$5.69 ▲ +0.24
(+4.40%)
MKT CAP: $585.2M • VOL: 259.0K
52W L $3 52W H $6
SBC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $173.6M | $205.4M | $193.5M |
| YoY Revenue Growth % | -15.5% | +6.1% | — |
| Gross Profit | $127.3M | $156.1M | — |
| Gross Margin % | 73.3% | 76.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $67.5M | $70.3M | $70.7M |
| Operating Margin % | 38.9% | 34.2% | 36.5% |
| Net Income (GAAP) | $51.0M | $46.6M | $39.4M |
| EBITDA (Normalized) | $68.6M | $72.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $24.7M | $20.6M | $50.7M |
| Capital Expenditures (CapEx) | $1.4M | $2.6M | — |
| Free Cash Flow (FCF) | $23.3M | $18.0M | $50.7M |
| FCF Margin % | 13.4% | 8.8% | 26.2% |
| Return on Invested Capital (ROIC %) | 63.1% | 79.3% | — |
| Cash & Short-Term Equivalents | $163.8M | $125.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $248.3M | $195.1M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SBC.